Estrogens, the be-all and end-all of male hypogonadal bone loss?
详细信息 查看全文
- 作者：M. R. Laurent (1) (2) (3)
E. Gielen (1) (2)
D. Vanderschueren (2) (4) (5)
1. Gerontology and Geriatrics ; Department of Clinical and Experimental Medicine ; KU Leuven ; Leuven ; Belgium
2. Centre for Metabolic Bone Diseases ; University Hospitals Leuven ; Leuven ; Belgium
3. Laboratory of Molecular Endocrinology ; Department of Cellular and Molecular Medicine ; KU Leuven ; Herestraat 49 ; PO box 901 ; 3000 ; Leuven ; Belgium
4. Clinical and Experimental Endocrinology ; Department of Clinical and Experimental Medicine ; KU Leuven ; Leuven ; Belgium
5. Endocrinology and Andrology ; University Hospitals Leuven ; Leuven ; Belgium - 刊名：Osteoporosis International
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：26
- 期：1
- 页码：29-33
- 全文大小：147 KB
- 参考文献：1. Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239鈥?256 CrossRef
2. Hiligsmann M, Bruy猫re O, Roberfroid D, Dubois C, Parmentier Y, Carton J et al (2012) Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000鈥?007). Arthritis Care Res (Hoboken) 64(5):744鈥?50 CrossRef
3. Laurent M, Gielen E, Claessens F, Boonen S, Vanderschueren D (2013) Osteoporosis in older men: recent advances in pathophysiology and treatment. Best Pract Res Clin Endocrinol Metab 27(4):527鈥?39 CrossRef
4. Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 29(3):581鈥?89 CrossRef
5. Siggeirsdottir K, Aspelund T, Jonsson BY, Mogensen B, Gudmundsson EF, Gudnason V et al (2014) Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989鈥?008. Osteoporos Int 25(1):211鈥?19 CrossRef
6. Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23(3):279鈥?02 CrossRef
7. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J et al (1997) Age and gender comparisons of muscle strength in 654 women and men aged 20鈥?3聽yr. J Appl Physiol (1985) 83(5):1581鈥?587
8. Tajar A, Huhtaniemi IT, O鈥橬eill TW, Finn JD, Pye SR, Lee DM et al (2012) Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 97(5):1508鈥?516 CrossRef
9. Van Caenegem E, Wierckx K, Taes Y, Schreiner T, Vandewalle S, Toye K, et al. (2014) Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporos Int. doi:10.1007/s00198-014-2805-3
10. Van Caenegem E, Wierckx K, Taes Y, Dedecker D, Van de Peer F, Toye K et al (2012) Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. J Clin Endocrinol Metab 97(7):2503鈥?511 CrossRef
11. Laurent M, Antonio L, Sinnesael M, Dubois V, Gielen E, Claessens F et al (2014) Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl 16(2):213鈥?22 CrossRef
12. Callewaert F, Venken K, Ophoff J, De Gendt K, Torcasio A, van Lenthe GH et al (2009) Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J 23(1):232鈥?40 CrossRef
13. Wiren KM, Zhang XW, Toombs AR, Kasparcova V, Gentile MA, Harada S et al (2004) Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology 145(7):3507鈥?522 CrossRef
14. Dubois V, Laurent MR, Sinnesael M, Cielen N, Helsen C, Clinckemalie L et al (2014) A satellite cell-specific knockout of the androgen receptor reveals myostatin as a direct androgen target in skeletal muscle. FASEB J 28(7):2979鈥?994 CrossRef
15. Ophoff J, Van Proeyen K, Callewaert F, De Gendt K, De Bock K, Vanden Bosch A et al (2009) Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology 150(8):3558鈥?566 CrossRef
16. McInnes KJ, Smith LB, Hunger NI, Saunders PT, Andrew R, Walker BR (2012) Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes 61(5):1072鈥?081 CrossRef
17. Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV et al (2006) Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res 21(4):576鈥?85 CrossRef
18. Argoud T, Boutroy S, Claustrat B, Chapurlat R, Szulc P (2014) Association between sex steroid levels and bone microarchitecture in men: the STRAMBO study. J Clin Endocrinol Metab 99(4):1400鈥?410 CrossRef
19. Ward KA, Pye SR, Adams JE, Boonen S, Vanderschueren D, Borghs H et al (2011) Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int 22(5):1513鈥?523 CrossRef
20. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85(9):3276鈥?282
21. Renoud A, Ecochard R, Marchand F, Chapurlat R, Szulc P (2014) Predictive parameters of accelerated muscle loss in men-MINOS study. Am J Med 127(6):554鈥?61 CrossRef
22. Amin S, Zhang Y, Felson DT, Sawin CT, Hannan MT, Wilson PW et al (2006) Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119(5):426鈥?33 CrossRef
23. Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL et al (2008) Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 168(1):47鈥?4 CrossRef
24. LeBlanc ES, Nielson CM, Marshall LM, Lapidus JA, Barrett-Connor E, Ensrud KE et al (2009) The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab 94(9):3337鈥?346 CrossRef
25. Woo J, Kwok T, Leung JC, Ohlsson C, Vandenput L, Leung PC (2012) Sex steroids and bone health in older Chinese men. Osteoporos Int 23(5):1553鈥?562 CrossRef
26. Khosla S (2010) Update in male osteoporosis. J Clin Endocrinol Metab 95(1):3鈥?0 CrossRef
27. Laurent MR, Vanderschueren D (2014) Reproductive endocrinology: functional effects of sex hormone-binding globulin variants. Nat Rev Endocrinol. doi:10.1038/nrendo.2014.120
28. Smith MR, Fallon MA, Lee H, Finkelstein JS (2004) Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 89(8):3841鈥?846 CrossRef
29. Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D et al (2010) Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol 184(4):1316鈥?321 CrossRef
30. Burnett-Bowie SA, McKay EA, Lee H, Leder BZ (2009) Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab 94(12):4785鈥?792 CrossRef
31. Idan A, Griffiths KA, Harwood DT, Seibel MJ, Turner L, Conway AJ et al (2010) Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. Ann Intern Med 153(10):621鈥?32 CrossRef
32. Falahati-Nini A, Riggs BL, Atkinson EJ, O鈥橣allon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106(12):1553鈥?560 CrossRef
33. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS (2003) Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88(1):204鈥?10 CrossRef
34. Meier C, Liu PY, Ly LP, de Winter-Modzelewski J, Jimenez M, Handelsman DJ et al (2004) Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 89(6):3033鈥?041 CrossRef
35. Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF et al (2013) Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 369(11):1011鈥?022 CrossRef
36. Yu E, Wulcyzn K, Webb W, Perros N, Bouxsein M, Finkelstein J (2012) Hypogonadism with Estrogen Removal (HER): differential effects of androgens and estrogens on bone microarchitecture in adult men. J Bone Miner Res 27(Suppl 1)
37. Tracz MJ, Sideras K, Bolona ER, Haddad RM, Kennedy CC, Uraga MV et al (2006) Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 91(6):2011鈥?016 CrossRef
38. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363(2):109鈥?22 CrossRef
39. Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism鈥攂eyond testosterone. Nat Rev Endocrinol 9(9):548鈥?54 CrossRef
40. Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman DJ et al (2010) Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A 107(52):22629鈥?2634 CrossRef
41. Uihlein AV, Finkelstein JS, Lee H, Leder BZ (2014) FSH suppression does not affect bone turnover in eugonadal men. J Clin Endocrinol Metab 99(7):2510鈥?515 CrossRef
42. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL et al (2007) Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148(4):1654鈥?665 CrossRef
43. Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S et al (2006) Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91(5):1848鈥?854 CrossRef
44. Foresta C, Strapazzon G, De Toni L, Perilli L, Di Mambro A, Muciaccia B et al (2011) Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 96(4):E646鈥揈652 CrossRef
45. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44(5):491鈥?01 CrossRef
46. Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J et al (2013) Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 123(6):2421鈥?433 CrossRef
47. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LY et al (2013) Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res 28(6):1348鈥?354 CrossRef
48. Andrews NA (2013) Skeletal regulation of glucose metabolism: challenges in translation from mouse to man. IBMS BoneKEy 10(353) doi:10.1038/bonekey.2013.87 - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Orthopedics
Gynecology
Endocrinology
Rheumatology - 出版者：Springer London
- ISSN：1433-2965
文摘